Feline CNP antibody and antigen (recombinant protein)
Diagnostic anti-Feline CNP antibodies pairs and antigen for animal health (animal Cat/Feline cardiovascular disease) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-FEL-CNP-Ag01 | Recombinant Feline CNP protein | 3090 |
GMP-FEL-CNP-Ab01 | Anti-Feline CNP mouse monoclonal antibody (mAb) | 3090 |
GMP-FEL-CNP-Ab02 | Anti-Feline CNP mouse monoclonal antibody (mAb) | 3090 |
GMP-FEL-CNP-Ab03 | Anti-Feline CNP human monoclonal antibody (mAb) | 3090 |
GMP-FEL-CNP-Ab04 | Anti-Feline CNP human monoclonal antibody (mAb) | 3090 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-FEL-CNP-Ag01 |
Product Name | Recombinant Feline CNP protein |
Target/Biomarker | Canine Human Angiotensin Converting Enzyme 2 (ACE2/hFc) |
Alias of Target/Biomarker | Canine Human Angiotensin Converting Enzyme 2 (ACE2/hFc) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Canine Human Angiotensin Converting Enzyme 2 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in ACE2/hFc level test of animal Cat/Feline with cardiovascular disease. |
Tag | His |
Products description | Recombinant Feline CNP protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-FEL-CNP-Ab01, GMP-FEL-CNP-Ab02 |
Product Name | Anti-Feline CNP mouse monoclonal antibody (mAb) |
Target/Biomarker | Canine Human Angiotensin Converting Enzyme 2 (ACE2/hFc) |
Alias of Target/Biomarker | Canine Human Angiotensin Converting Enzyme 2 (ACE2/hFc) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Canine Human Angiotensin Converting Enzyme 2 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-ACE2/hFc antibodies in ACE2/hFc level test of animal Cat/Feline with cardiovascular disease. |
Tag | mFc |
Products description | Anti-Feline CNP mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-ACE2/hFc antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-FEL-CNP-Ab03, GMP-FEL-CNP-Ab04 |
Product Name | Anti-Feline CNP human monoclonal antibody (mAb) |
Target/Biomarker | Canine Human Angiotensin Converting Enzyme 2 (ACE2/hFc) |
Alias of Target/Biomarker | Canine Human Angiotensin Converting Enzyme 2 (ACE2/hFc) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Canine Human Angiotensin Converting Enzyme 2 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-ACE2/hFc antibodies in ACE2/hFc level test of animal Cat/Feline with cardiovascular disease. |
Tag | hFc |
Products description | Anti-Feline CNP human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-ACE2/hFc antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
In cats, CNP demonstrates diverse roles beyond its cardiovascular effects. Here are some additional perspectives on Cat/Feline CNP: a) Vascular Development: CNP plays a crucial role in vascular development and angiogenesis during embryonic development. It contributes to the formation of blood vessels by promoting endothelial cell proliferation, migration, and tube formation. b) Skeletal Growth: CNP is involved in regulating the growth and development of long bones through its effects on the growth plates. It modulates chondrocyte proliferation, differentiation, and matrix synthesis in the growth plates, influencing bone growth and skeletal development. c) Reproductive System: CNP has been identified in the reproductive tissues of cats, including the ovaries and testes. It may play a role in follicular development, ovulation, and spermatogenesis, although further research is needed to fully understand its functions in the reproductive system. d) Stress Response: CNP levels can be influenced by stress and certain pathological conditions. Monitoring CNP in cats exposed to stressful situations or experiencing conditions like heart disease can provide insights into the physiological responses to stress and pathological stress-related changes.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.